Cargando…

Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects

Detalles Bibliográficos
Autores principales:	Kaur, Mandeep, Dlamini, Zodwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521540/ https://www.ncbi.nlm.nih.gov/pubmed/36186465 http://dx.doi.org/10.3389/fgene.2022.994181

Ejemplares similares

Editorial: Women in science: Genetics
por: de Vasconcellos, Jaira Ferreira, et al.
Publicado: (2022)

Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
por: Kumar, Navneet, et al.
Publicado: (2021)

Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making
por: Mbatha, Sikhumbuzo, et al.
Publicado: (2022)

Editorial: Uncovering Drug Resistance During Cancer Therapy
por: Wang, Haitao, et al.
Publicado: (2022)

LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022)

Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer
por: Abdulla, Naaziyah, et al.
Publicado: (2021)

microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
por: Monchusi, Bernice, et al.
Publicado: (2020)

Can the HIV-1 splicing machinery be targeted for drug discovery?
por: Dlamini, Zodwa, et al.
Publicado: (2017)

Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
por: Francies, Flavia Zita, et al.
Publicado: (2021)

Editorial: Epigenetic and Transcriptional Dysregulations in Cancer and Therapeutic Opportunities
por: Ansari, Rais A., et al.
Publicado: (2022)

MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
por: Marima, Rahaba, et al.
Publicado: (2021)

Editorial: Genetic and epigenetic aspects of non-coding RNAs in physiology and disease
por: Adelman Cipolla, Gabriel, et al.
Publicado: (2022)

Editorial: Epigenetics in Cancer: Mechanisms and Drug Development
por: Yuan, Huiqing, et al.
Publicado: (2022)

Editorial: Role of RNA in Molecular Diagnostics of Cancer
por: Cho, William C. S., et al.
Publicado: (2020)

Aspects of Molecular Genetics in Dromedary Camel
por: Piro, Mohammed
Publicado: (2021)

Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets
por: Mbita, Zukile, et al.
Publicado: (2014)

Editorial: RNA Modification in Human Cancers: Roles and Therapeutic Implications
por: Zhou, You, et al.
Publicado: (2022)

Editorial: Cancer evolution: From biological insights to therapeutic opportunities
por: Davis, Andrew A., et al.
Publicado: (2022)

Editorial: Molecular basis of epigenetic regulation in cancer therapies
por: Carlos-Reyes, Angeles, et al.
Publicado: (2023)

The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer
por: Marima, Rahaba, et al.
Publicado: (2021)

Editorial: Epigenetics in cancer: mechanisms and drug development-volume II
por: Zhu, Xiao, et al.
Publicado: (2023)

Editorial: Molecular aspects of compulsive drug use
por: Lasek, Amy W., et al.
Publicado: (2023)

Editorial: Genetics and ontogeny in precision therapeutics for children
por: Chen, Feng, et al.
Publicado: (2023)

Editorial: Computational Methods in Inferring Cancer Tissue-of-Origin and Cancer Molecular Classification
por: Kui, Ling, et al.
Publicado: (2021)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Editorial: New insights in cellular and molecular biology of cancer stem cells
por: Vazquez-Santillan, Karla, et al.
Publicado: (2023)

Editorial: Methods and Applications in Molecular Phylogenetics
por: Wang, Juan
Publicado: (2022)

Neurodevelopment in Children Exposed to Zika in utero: Clinical and Molecular Aspects
por: Schuler-Faccini, Lavínia, et al.
Publicado: (2022)

Editorial: Exosomes, miRNAs, and lncRNAs in breast cancer: Therapeutic and diagnostic applications
por: Hashemi, Zahra Sadat, et al.
Publicado: (2023)

Editorial: Neurodegeneration: From Disease Mechanism to Therapeutic Advancement
por: Sarkar, Partha S., et al.
Publicado: (2022)

Evolutionary and Biochemical Aspects of Chemical Stress Resistance in Saccharomyces cerevisiae
por: Venancio, Thiago Motta, et al.
Publicado: (2012)

Editorial: Genetics and molecular breeding in aquaculture animals
por: Yu, Yue, et al.
Publicado: (2022)

Editorial: Cancer Diagnostic and Therapeutic Target Identification and Verification Based on the Regulatory Functions of MicroRNAs
por: Chan, Lawrence W. C., et al.
Publicado: (2017)

Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeutics
por: Mathiyalagan, Prabhu, et al.
Publicado: (2023)

Editorial: Functional screening for cancer drug discovery: from experimental approaches to data integration
por: Zhou, Kecheng, et al.
Publicado: (2023)

Bioinformatics Analysis Identifies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs
por: Peng, Ying, et al.
Publicado: (2021)

Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance
por: Buroni, Silvia, et al.
Publicado: (2019)

Editorial: Molecular Mechanisms of Heritable Connective Tissue Disorders
por: Malfait, Fransiska, et al.
Publicado: (2022)

Editorial: Mitochondrial Disorders: Biochemical and Molecular Basis of Disease
por: Leipnitz, Guilhian, et al.
Publicado: (2021)

Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models
por: Awah, Chidiebere U., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jukv8us7jlmc2c7opsfnae7f0m